Antibodies generated<i>in vitro</i>and<i>in vivo</i>elucidate design of a thermostable ADDomer COVID-19 nasal nanoparticle vaccine
Abstract COVID-19 continues to damage populations, communities and economies worldwide. Vaccines have reduced COVID-19-related hospitalisations and deaths, primarily in developed countries. Persisting infection rates, and highly transmissible SARS-CoV-2 Variants of Concern (VOCs) causing repeat and breakthrough infections, underscore the ongoing need for new treatments to achieve a global solution. Based on ADDomer, a self-assembling protein nanoparticle scaffold, we created ADDoCoV, a thermostable COVID-19 candidate vaccine displaying multiple copies of a SARS-CoV-2 receptor binding motif (RBM)-derived epitope.In vitrogenerated neutralising nanobodies combined with molecular dynamics (MD) simulations and electron cryo-microscopy (cryo-EM) established authenticity and accessibility of the epitopes displayed. A Gigabody comprising multimerized nanobodies prevented SARS-CoV-2 virion attachment with picomolar EC50. Antibodies generated by immunising mice cross-reacted with VOCs including Delta and Omicron. Our study elucidates nasal administration of ADDomer-based nanoparticles for active and passive immunisation against SARS-CoV-2 and provides a blueprint for designing nanoparticle reagents to combat respiratory viral infections..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
bioRxiv.org - (2023) vom: 09. Dez. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2023.03.17.533092 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI038996065 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI038996065 | ||
| 003 | DE-627 | ||
| 005 | 20231210091139.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230320s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2023.03.17.533092 |2 doi | |
| 035 | |a (DE-627)XBI038996065 | ||
| 035 | |a (biorXiv)10.1101/2023.03.17.533092 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Buzas, Dora |e verfasserin |0 (orcid)0000-0003-3883-6340 |4 aut | |
| 245 | 1 | 0 | |a Antibodies generated<i>in vitro</i>and<i>in vivo</i>elucidate design of a thermostable ADDomer COVID-19 nasal nanoparticle vaccine |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract COVID-19 continues to damage populations, communities and economies worldwide. Vaccines have reduced COVID-19-related hospitalisations and deaths, primarily in developed countries. Persisting infection rates, and highly transmissible SARS-CoV-2 Variants of Concern (VOCs) causing repeat and breakthrough infections, underscore the ongoing need for new treatments to achieve a global solution. Based on ADDomer, a self-assembling protein nanoparticle scaffold, we created ADDoCoV, a thermostable COVID-19 candidate vaccine displaying multiple copies of a SARS-CoV-2 receptor binding motif (RBM)-derived epitope.In vitrogenerated neutralising nanobodies combined with molecular dynamics (MD) simulations and electron cryo-microscopy (cryo-EM) established authenticity and accessibility of the epitopes displayed. A Gigabody comprising multimerized nanobodies prevented SARS-CoV-2 virion attachment with picomolar EC50. Antibodies generated by immunising mice cross-reacted with VOCs including Delta and Omicron. Our study elucidates nasal administration of ADDomer-based nanoparticles for active and passive immunisation against SARS-CoV-2 and provides a blueprint for designing nanoparticle reagents to combat respiratory viral infections. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Bunzel, H Adrian |0 (orcid)0000-0001-6427-368X |4 aut | |
| 700 | 1 | |a Staufer, Oskar |0 (orcid)0000-0002-8015-3132 |4 aut | |
| 700 | 1 | |a Milodowski, Emily J |0 (orcid)0000-0001-8452-1177 |4 aut | |
| 700 | 1 | |a Edmunds, Grace L |0 (orcid)0000-0001-7376-8617 |4 aut | |
| 700 | 1 | |a Bufton, Joshua C |0 (orcid)0000-0001-6891-6515 |4 aut | |
| 700 | 1 | |a Vidana Mateo, Beatriz V |0 (orcid)0000-0003-1724-1006 |4 aut | |
| 700 | 1 | |a Yadav, Sathish K N |0 (orcid)0000-0003-0779-0941 |4 aut | |
| 700 | 1 | |a Gupta, Kapil |0 (orcid)0000-0002-2115-3503 |4 aut | |
| 700 | 1 | |a Fletcher, Charlotte |0 (orcid)0000-0001-5037-3719 |4 aut | |
| 700 | 1 | |a Kavanagh Williamson, Maia |0 (orcid)0000-0002-4659-8613 |4 aut | |
| 700 | 1 | |a Harrison, Alexandra |4 aut | |
| 700 | 1 | |a Borucu, Ufuk |0 (orcid)0000-0001-6746-5409 |4 aut | |
| 700 | 1 | |a Capin, Julien |0 (orcid)0000-0002-5929-2955 |4 aut | |
| 700 | 1 | |a Francis, Ore |0 (orcid)0000-0003-2678-917X |4 aut | |
| 700 | 1 | |a Balchin, Georgia |4 aut | |
| 700 | 1 | |a Hall, Sophie |4 aut | |
| 700 | 1 | |a Vivoli Vega, Mirella |0 (orcid)0000-0002-1148-5651 |4 aut | |
| 700 | 1 | |a Durbesson, Fabien |0 (orcid)0000-0001-7972-2054 |4 aut | |
| 700 | 1 | |a Vincentelli, Renaud |0 (orcid)0000-0001-9667-0196 |4 aut | |
| 700 | 1 | |a Roe, Joe |0 (orcid)0000-0002-1011-1244 |4 aut | |
| 700 | 1 | |a Wooldridge, Linda |0 (orcid)0000-0002-6213-347X |4 aut | |
| 700 | 1 | |a Burt, Rachel |0 (orcid)0000-0001-8827-8266 |4 aut | |
| 700 | 1 | |a Anderson, J L Ross |0 (orcid)0000-0002-6796-0482 |4 aut | |
| 700 | 1 | |a Mulholland, Adrian J |0 (orcid)0000-0003-1015-4567 |4 aut | |
| 700 | 1 | |a Hare, Jonathan |4 aut | |
| 700 | 1 | |a Bailey, Mick |4 aut | |
| 700 | 1 | |a Davidson, Andrew D |0 (orcid)0000-0002-1136-4008 |4 aut | |
| 700 | 1 | |a Finn, Adam |0 (orcid)0000-0003-1756-5668 |4 aut | |
| 700 | 1 | |a Morgan, David |4 aut | |
| 700 | 1 | |a Mann, Jamie |0 (orcid)0000-0001-7037-1286 |4 aut | |
| 700 | 1 | |a Spatz, Joachim |0 (orcid)0000-0003-3419-9807 |4 aut | |
| 700 | 1 | |a Garzoni, Frederic |0 (orcid)0000-0002-3589-6682 |4 aut | |
| 700 | 1 | |a Schaffitzel, Christiane |0 (orcid)0000-0002-1516-9760 |4 aut | |
| 700 | 1 | |a Berger, Imre |0 (orcid)0000-0001-7518-9045 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 09. Dez. |
| 773 | 1 | 8 | |g year:2023 |g day:09 |g month:12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2023.03.17.533092 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 09 |c 12 | ||